Plain-English translation of NCT05300464 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new breast imaging technology called MammoWave, which uses microwave signals instead of X-rays to detect breast lesions (both cancerous and benign growths). Researchers want to see if this method can accurately find breast abnormalities that doctors have already identified using standard screening methods like mammography. The study will include about 600 women at medical centers in Italy, Germany, and Spain.
Current breast screening methods like mammography are helpful but have limitations—they can sometimes miss lesions or cause discomfort. This trial is exploring whether the new treatment offers doctors another tool that could be safer, more comfortable, or better at detecting breast abnormalities.
You likely qualify if…
You likely don't qualify if…
You will have a standard breast screening (mammogram or ultrasound) as you normally would, and then you'll also receive the MammoWave scan at the same visit or shortly after. The study has two phases: first, researchers will set up and test the MammoWave equipment at each center, then they'll scan women with and without known breast lesions to see how well the technology detects abnormalities. Your results from MammoWave will be compared with your standard imaging results to measure how accurate the new method is.
AI-generated summary from trial data · Jul 12, 2026 · Not medical advice
Italy
Spain